Asia Pacific Medical Imaging Market (By Product: X-ray Devices, Ultrasound, Computed Tomography, Magnetic Resonance Imaging; By End-Use: Hospitals, Diagnostic Imaging Centers) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Asia Pacific Medical Imaging Market Size and Trends

The Asia Pacific medical imaging market size was estimated at around USD 8.63 billion in 2023 and it is projected to hit around USD 14.85 billion by 2033, growing at a CAGR of 5.58% from 2024 to 2033.

Asia Pacific Medical Imaging Market Size 2024 to 2033

Key Pointers

  • Asia Pacific led the market with the largest market share of 22% in 2023.
  • Japan's medical imaging market is anticipated to grow at the fastest CAGR of 5.93% from 2024 to 2033.
  • By Product, the ultrasound segment held the largest revenue share of 33% in 2023.
  • By Product, the CT segment is projected to experience the fastest growth during the forecast period.
  • By End-use, the hospitals accounted for the largest share of 43% in 2023.

Asia Pacific Medical Imaging Market Overview

The Asia Pacific region is witnessing significant growth in the medical imaging market, driven by technological advancements, increasing healthcare expenditure, and a rising prevalence of chronic diseases. Medical imaging plays a crucial role in diagnosing and monitoring various medical conditions, thereby supporting better patient outcomes and treatment decisions.

Asia Pacific Medical Imaging Market Growth Factors

The growth of the Asia Pacific medical imaging market is fueled by the technological advancements in imaging modalities such as MRI, CT scans, ultrasound, and PET-CT have significantly enhanced diagnostic capabilities, driving increased adoption across the region. Rising healthcare expenditure, particularly in countries like China and India, is supporting the expansion of healthcare infrastructure and the integration of advanced imaging technologies. Additionally, the escalating prevalence of chronic diseases, including cardiovascular disorders and cancer, is driving the demand for medical imaging solutions for early diagnosis and treatment planning. Government initiatives aimed at improving healthcare access and quality further contribute to market growth by encouraging the adoption of advanced medical imaging systems.

Asia Pacific Medical Imaging Market Trends:

  • Rising Adoption of AI and Machine Learning: Integration of artificial intelligence and machine learning algorithms into imaging systems for automated analysis and enhanced efficiency.
  • Shift towards Digital Imaging: Increasing preference for digital imaging systems over traditional film-based methods due to advantages in storage, accessibility, and image quality.
  • Growing Telemedicine and Remote Imaging: Expansion of telemedicine services driving the demand for portable and remote imaging devices that facilitate diagnostics in remote locations.
  • Focus on Radiation Dose Reduction: Emphasis on developing imaging technologies that minimize radiation exposure without compromising diagnostic quality.
  • Personalized Medicine: Increasing use of medical imaging for personalized treatment plans tailored to individual patient profiles, particularly in oncology and neurology.

Asia Pacific Medical Imaging Market Restraints:

  • High Costs: The initial investment and operational costs associated with advanced medical imaging technologies such as MRI and CT scanners can be prohibitive for healthcare providers, particularly in developing economies.
  • Limited Access to Healthcare Facilities: Uneven distribution of healthcare facilities and imaging equipment across rural and remote areas within the Asia Pacific region restricts access to medical imaging services for a significant portion of the population.
  • Concerns over Radiation Exposure: Despite technological advancements in reducing radiation doses, there remains a persistent concern among patients and healthcare providers regarding potential health risks associated with frequent imaging procedures.
  • Complex Regulatory Environment: Varied regulatory frameworks across different countries within the Asia Pacific region can create barriers to market entry and hinder the adoption of new imaging technologies.

Product Insights

In 2023, the ultrasound segment dominated with a substantial share of 33% and is poised to maintain its leadership throughout the forecast period. The segment's growth is driven by the expanding applications of ultrasound technology. Recent advancements in ultrasound transducers have opened new avenues in biomedical and cardiovascular imaging. Moreover, the development of portable ultrasound devices is expected to broaden their utility in ambulatory and emergency care settings. Integration of artificial intelligence for automated image quantification and selection is also anticipated to bolster market growth.

The CT segment is projected to experience the fastest growth during the forecast period. This growth is primarily attributed to the increasing demand for point-of-care CT devices and advancements such as high-precision CT scanners integrating artificial intelligence, machine learning, and advanced visualization systems.

End-use Insights

Hospitals accounted for the largest share of 43% in 2023. The demand for advanced imaging modalities and the integration of imaging technologies into surgical suites are key factors driving segment growth. Teaching hospitals, in particular, have witnessed a significant rise in demand for these modalities compared to general or specialty hospitals. The establishment of new hospitals with dedicated space for imaging modalities is expected to further drive segment growth, fueled by competitive pressures and the demand for high-quality healthcare services.

The diagnostic imaging centers segment is expected to witness significant growth due to increasing awareness of chronic diseases such as cancer and neurological disorders. This has led to higher demand for CT and MRI procedures essential for diagnosis, treatment planning, and prevention of chronic illnesses. Investments in advanced technology, infrastructure improvement, and substantial funding are contributing to the segment's growth trajectory.

Country Insights

In 2023, the Asia Pacific medical imaging market held a share of 22%. Factors such as demographic changes, evolving disease patterns, and growth in the private healthcare sector are expected to propel market growth. The rise of private hospitals offering specialized care, including maternity and orthopedic treatments, is attributed to increasing foreign investments in the healthcare sector.

China led the Asia Pacific medical imaging market in 2023 with the largest revenue share. The country's growing number of hospitals is driving demand for medical imaging devices, which are integral to modern healthcare facilities. However, navigating China's complex and evolving regulatory environment remains a challenge for companies entering the market. Despite regulatory hurdles, China presents significant opportunities for U.S. companies aiming to expand their presence.

Japan's medical imaging market is anticipated to grow at the fastest CAGR of 5.93% during the forecast period. The country boasts well-equipped healthcare facilities with advanced imaging technologies. Increasing adoption of medical imaging devices in primary care settings and clinics is supported by the availability of affordable, novel imaging solutions and growing interest among physicians in early clinical interventions.

India, with its burgeoning demand for maternity services evidenced by the highest number of New Year’s Day births globally, is poised to drive the adoption of medical imaging devices. Manufacturers are actively expanding their operations in India, exemplified by Philips' recent investment in Maharashtra. This expansion includes facilities for MRI radio frequency coils, mobile surgery systems, and ultrasound assembly, reflecting India's growing importance in the medical imaging market.

Asia Pacific Medical Imaging Market Key Companies

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Mindray Medical International
  • Esaote
  • Hologic, Inc.
  • Samsung Medison Co., Ltd.
  • Koning Corporation
  • PerkinElmer Inc.
  • FUJIFILM VisualSonics Inc.
  • Cubresa Inc.

Recent Developments

  • In January 2022, United Imaging announced a strategic partnership with the King Hussein Cancer Center (KHCC). This collaboration aimed to advance oncology and molecular imaging while enhancing healthcare delivery through academic exchanges, clinical research applications, and talent development initiatives.
  • In November 2022, Canon, Inc. unveiled plans to establish a new subsidiary, Canon Healthcare USA, INC., signaling its strategic expansion in the American medical market to bolster its medical business.
  • In May 2021, United Imaging introduced its uAIFI Technology Platform for magnetic resonance imaging and uExcel Technology Platform for PET/CT during the China International Medical Equipment Fair (CMEF).

Asia Pacific Medical Imaging Market Segmentation:

By Product

  • X-ray Devices
    • By Modality
      • Radiography
      • Fluoroscopy
      • Mammography
  • Ultrasound
    • By Portability
    • Handheld
    • Cart/Trolley Based
  • Computed Tomography
    • By Technology
      • High end slice
      • Mid end slice
      • Low end slice
      • Cone beam
  • Magnetic Resonance Imaging
    • By Architecture
      • Closed System
      • Open System
  • Nuclear Imaging
    • By Product
      • SPECT
      • PET

By End-use

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

By Country

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand

Frequently Asked Questions

The Asia Pacific medical imaging market size was reached at USD 8.63 billion in 2023 and it is projected to hit around USD 14.85 billion by 2033.

The Asia Pacific medical imaging market is growing at a compound annual growth rate (CAGR) of 5.58% from 2024 to 2033.

The driving factors of the Asia Pacific medical imaging market include technological advancements, increasing healthcare expenditure, rising chronic disease burden, and growing demand for early and accurate diagnosis.

The leading companies operating in the Asia Pacific medical imaging market are GE Healthcare; Koninklijke Philips N.V.; Siemens Healthineers; Koninklijke Philips N.V., Canon Medical Systems Corporation, Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc. and Cubresa Inc.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Asia Pacific Medical Imaging Market 

5.1. COVID-19 Landscape: Asia Pacific Medical Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Asia Pacific Medical Imaging Market, By        

8.1. Asia Pacific Medical Imaging Market, by Product, 2024-2033

8.1.1. X-ray Devices

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Ultrasound

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Computed Tomography

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Magnetic Resonance Imaging

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Nuclear Imaging

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Asia Pacific Medical Imaging Market, By End-use

9.1. Asia Pacific Medical Imaging Market, by End-use, 2024-2033

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Diagnostic Imaging Centers

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Asia Pacific Medical Imaging Market, Regional Estimates and Trend Forecast

10.1. Asia Pacific

10.1.1. Market Revenue and Forecast, by Product (2021-2033)

10.1.2. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 11. Company Profiles

11.1. GE Healthcare

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Koninklijke Philips N.V.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Siemens Healthineers

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Canon Medical Systems Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. Mindray Medical International

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Esaote

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Hologic, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Samsung Medison Co., Ltd.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Koning Corporation

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. PerkinElmer Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers